Position in LLY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$8,291,660
+$1,942,488 QoQ
Shares Held
6,913
+0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
6.14%
of 13F equity value
Holder Rank
#1,362
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026bLong Financial, LLC holds $15,967,253 across 9 Drug Manufacturers - General names. LLY ranks #1 (51.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
6,913 | $8,291,660 | |
| 2 | MRK |
Merck & Co., Inc.
|
18,742 | $2,408,347 | |
| 3 | JNJ |
Johnson & Johnson
|
5,720 | $1,452,708 | |
| 4 | AMGN |
Amgen Inc
|
3,050 | $1,104,466 | |
| 5 | ABBV |
AbbVie Inc.
|
4,307 | $1,083,813 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
15,052 | $867,296 | |
| 7 | PFE |
Pfizer Inc
|
13,727 | $330,546 | |
| 8 | AZN |
Astrazeneca PLC
|
1,138 | $215,787 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,291,660 | 6,913 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $6,349,172 | 6,903 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $7,536,731 | 7,013 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $5,350,919 | 7,013 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $5,466,843 | 7,013 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,750,811 | 6,963 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,367,716 | 6,953 | Shares | Sole | 2025-01-30 | |
| No filing history on record for this holder in this stock. | ||||||